X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Elder Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ELDER PHARMA - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ELDER PHARMA ABBOTT INDIA/
ELDER PHARMA
 
P/E (TTM) x 42.3 -0.2 - View Chart
P/BV x 10.6 0.1 10,472.4% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 ABBOTT INDIA   ELDER PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
ELDER PHARMA
Jun-14
ABBOTT INDIA/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs6,015380 1,582.9%   
Low Rs3,707188 1,971.8%   
Sales per share (Unadj.) Rs1,236.9491.2 251.8%  
Earnings per share (Unadj.) Rs122.2-3.2 -3,840.2%  
Cash flow per share (Unadj.) Rs129.014.4 895.1%  
Dividends per share (Unadj.) Rs35.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs521.2376.5 138.4%  
Shares outstanding (eoy) m21.2520.54 103.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.90.6 679.7%   
Avg P/E ratio x39.8-89.3 -44.6%  
P/CF ratio (eoy) x37.719.7 191.2%  
Price / Book Value ratio x9.30.8 1,236.4%  
Dividend payout %28.60-   
Avg Mkt Cap Rs m103,2965,833 1,770.8%   
No. of employees `0003.0NA-   
Total wages/salary Rs m3,3702,179 154.7%   
Avg. sales/employee Rs Th8,891.8NM-  
Avg. wages/employee Rs Th1,140.0NM-  
Avg. net profit/employee Rs Th878.3NM-  
INCOME DATA
Net Sales Rs m26,28410,089 260.5%  
Other income Rs m504257 196.6%   
Total revenues Rs m26,78910,346 258.9%   
Gross profit Rs m3,665-792 -462.9%  
Depreciation Rs m144361 40.0%   
Interest Rs m82,756 0.3%   
Profit before tax Rs m4,017-3,653 -110.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m1,421125 1,135.4%   
Profit after tax Rs m2,596-65 -3,972.9%  
Gross profit margin %13.9-7.8 -177.7%  
Effective tax rate %35.4-3.4 -1,032.4%   
Net profit margin %9.9-0.6 -1,525.0%  
BALANCE SHEET DATA
Current assets Rs m14,4469,240 156.3%   
Current liabilities Rs m4,7259,998 47.3%   
Net working cap to sales %37.0-7.5 -492.5%  
Current ratio x3.10.9 330.8%  
Inventory Days Days5146 111.0%  
Debtors Days Days2060 32.6%  
Net fixed assets Rs m1,11310,124 11.0%   
Share capital Rs m213206 103.3%   
"Free" reserves Rs m10,8085,582 193.6%   
Net worth Rs m11,0767,734 143.2%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m16,24122,882 71.0%  
Interest coverage x497.0-0.3 -152,774.8%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.60.4 367.1%   
Return on assets %16.011.8 136.4%  
Return on equity %23.4-0.8 -2,773.9%  
Return on capital %36.322.3 162.9%  
Exports to sales %0.63.0 20.2%   
Imports to sales %12.60.4 2,959.0%   
Exports (fob) Rs m162307 52.7%   
Imports (cif) Rs m3,32243 7,708.8%   
Fx inflow Rs m268307 87.4%   
Fx outflow Rs m3,927125 3,134.4%   
Net fx Rs m-3,659181 -2,018.4%   
CASH FLOW
From Operations Rs m2,51411,754 21.4%  
From Investments Rs m-800-561 142.6%  
From Financial Activity Rs m-803-6,762 11.9%  
Net Cashflow Rs m9124,432 20.6%  

Share Holding

Indian Promoters % 0.0 39.6 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 7.5 105.3%  
FIIs % 0.1 16.8 0.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 36.1 47.4%  
Shareholders   18,270 16,479 110.9%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   TORRENT PHARMA  NATCO PHARMA  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Rally, IMF's GDP Prediction, and Top Stocks in Action(Pre-Open)

On Tuesday, share markets in India opened in green and ended on a positive note. The BSE Sensex closed higher by 342 points to close above 36,000 levels for the first time ever.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jan 23, 2018 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS